The role of CYP1A1/2 in cholesterol ester accumulation provides a new perspective for the treatment of hypercholesterolemia
Cholesterol is an important precursor of many endogenous molecules. Disruption of cholesterol homeostasis can cause many pathological changes, leading to liver and cardiovascular diseases. CYP1A is widely involved in cholesterol metabolic network, but its exact function has not been fully elucidated...
Saved in:
Main Authors: | Jian Lu (Author), Xuyang Shang (Author), Bingyi Yao (Author), Dongyi Sun (Author), Jie Liu (Author), Yuanjin Zhang (Author), He Wang (Author), Jingru Shi (Author), Huaqing Chen (Author), Tieliu Shi (Author), Mingyao Liu (Author), Xin Wang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New insights of CYP1A in endogenous metabolism: a focus on single nucleotide polymorphisms and diseases
by: Jian Lu, et al.
Published: (2020) -
THE REDUCTION OF CHOLESTEROL WITH CUPPING THERAPY ON CHOLESTEROL REDUCTION IN PATIENTS WITH HYPERCHOLESTEROLEMIA
by: Zahid Fikri, et al.
Published: (2017) -
CYP11A1 silencing suppresses HMGCR expression via cholesterol accumulation and sensitizes CRPC cell line DU-145 to atorvastatin
by: Jiro Tashiro, et al.
Published: (2023) -
Untargeted and Targeted Metabolomics Reveal the Underlying Mechanism of Aspirin Eugenol Ester Ameliorating Rat Hyperlipidemia via Inhibiting FXR to Induce CYP7A1
by: Lu Xiao-Rong, et al.
Published: (2021) -
Characterization of organic anion transporting polypeptide 1b2 knockout rats generated by CRISPR/Cas9: a novel model for drug transport and hyperbilirubinemia disease
by: Xinrun Ma, et al.
Published: (2020)